New issue fully subscribed
Active Biotech AB's new share issue, with preferential rights to existing shareholders, has been fully subscribed.
The new issue generated proceeds to Active Biotech of approximately SEK 248 M, after deduction for issue expenses. As a result of the issue, the number of Series B shares increased by 1,891,496.
Following the issue, the number of shares in Active Biotech amounts to 9,457,482, comprising 2,315,660 Series A shares and 7,141,822 Series B shares.
Lund, 20 May 1998
Active Biotech AB (publ)
Bo Håkansson, Managing Director